{
  "pmcid": "4912949",
  "sha256": "f409bd8629bb7949cdbd2cdd1e7272c65aa568a5421ac8ab2069dddf0f82f9c8",
  "timestamp_utc": "2025-11-09T16:01:14.486402+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.218246753246756,
    "reading_ease": 44.6604653679654,
    "word_count": 308
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "This report describes the stereotactic technique, hospitalization, and 90-day perioperative safety of bilateral deep brain stimulation (DBS) of the fornix in patients who underwent DBS for the treatment of mild, probable Alzheimer’s disease (AD)."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "The ADvance Trial is a multicenter, 12-month, double-blind, randomized, controlled feasibility study being conducted to evaluate the safety, efficacy, and tolerability of DBS of the fornix in patients with mild, probable AD."
      },
      "Participants": {
        "score": 1,
        "evidence": "patients with mild, probable Alzheimer’s disease (AD)."
      },
      "Intervention": {
        "score": 2,
        "evidence": "bilateral deep brain stimulation (DBS) of the fornix in patients who underwent DBS for the treatment of mild, probable Alzheimer’s disease (AD)."
      },
      "Objective": {
        "score": 1,
        "evidence": "to evaluate the safety, efficacy, and tolerability of DBS of the fornix in patients with mild, probable AD."
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 2,
        "evidence": "double-blind"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Between June 6, 2012, and April 28, 2014, a total of 42 patients with mild, probable AD were treated with bilateral fornix DBS"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "Twenty-six (61.9%) patients experienced 64 AEs related to the study procedure, of which 7 were serious AEs experienced by 5 patients (11.9%)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Twenty-six (61.9%) patients experienced 64 AEs related to the study procedure, of which 7 were serious AEs experienced by 5 patients (11.9%)."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 11,
    "max_score": 25
  }
}